SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043062
Filing Date
2021-08-10
Accepted
2021-08-10 16:01:30
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-10q_20210630.htm   iXBRL 10-Q 3083720
2 EX-31.1 idya-ex311_8.htm EX-31.1 18311
3 EX-31.2 idya-ex312_6.htm EX-31.2 18368
4 EX-32.1 idya-ex321_7.htm EX-32.1 12425
  Complete submission text file 0001564590-21-043062.txt   8829904

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA idya-20210630.xsd EX-101.SCH 51748
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20210630_cal.xml EX-101.CAL 42769
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20210630_def.xml EX-101.DEF 176887
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20210630_lab.xml EX-101.LAB 418431
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20210630_pre.xml EX-101.PRE 318123
10 EXTRACTED XBRL INSTANCE DOCUMENT idya-10q_20210630_htm.xml XML 1467370
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 211159805
SIC: 2834 Pharmaceutical Preparations